New Delhi [India], July 25 (ANI): In a development related to the COVID-19 vaccine, the Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) for conducting the Phase 2/3 human clinical trials for a potential coronavirus vaccine.
London [UK], July 20 (ANI): A vaccine candidate developed at the University of Oxford has shown encouraging results in early human testing and appears to be "safe well-tolerated, and immunogenic", according to a study published in The Lancet.